Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neladenoson bialanate dose-finding in chronic heart failure with reduced ejection fraction
NL-OMON47145Phase 2Active, not recruiting
- Sponsor
- Bayer
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of neladenoson bialanate, sponsored by Bayer. Started Jul 2017; status: active, not recruiting.
02
Drugs
neladenoson bialanate
Beyond the preview
Go deeper on NL-OMON47145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47145.